BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Genetown

  PepGen Announces Upcoming Data Presentations at the 2023 American Academy of Neurology Annual Meeting

  PepGen Inc. (Nasdaq: PEPG) today announced that it will present at the 2023 American Academy of Neurology (AAN) Annual Meeting, taking place on April 22-27, 2023 in Boston, Massachusetts.

  April 17, 2023

   · 

  5 min read
• Genetown

  Praxis Precision Medicines Announces Upcoming Ulixacaltamide Presentations & Events

  Praxis Precision Medicines, Inc. announced the following upcoming ulixacaltamide presentations and events focused on Essential Tremor.

  April 17, 2023

   · 

  4 min read
• Business

  Enlivex Appoints Andrew Singer to its Board of Directors

  Enlivex Therapeutics Ltd., a clinical-stage macrophage reprogramming immunotherapy company, announced the appointment of Andrew Singer to its Board of Directors.

  April 17, 2023

   · 

  5 min read
• BioVie Announces Data Abstracts from NE3107 Phase 2 Trials Accepted for Presentation at AAN 2023

  BioVie Inc. today announced data abstracts from its Phase 2 trials evaluating NE7107 in degenerative dementias and Parkinson’s Disease will be presented at the 2023 American Academy of Neurology (AAN) Annual Meeting, to be held virtually and in Boston, MA, April 22-27, 2023.

  April 17, 2023

   · 

  4 min read
• Genetown

  Innovation Pharmaceuticals Brilacidin Antifungal Research Published in Nature Communications

  Innovation Pharmaceuticals, a clinical stage biopharmaceutical company, announced publication of Brilacidin antifungal research in Nature Communications, a leading peer-reviewed scientific journal.

  April 17, 2023

   · 

  4 min read
• FDA

  Candel Therapeutics Receives FDA Fast Track Designation for CAN-2409 in Non-Small Cell Lung Cancer

  Candel Therapeutics, Inc today announced that the U.S. Food and Drug Administration (FDA) granted fast track designation for its lead asset CAN-2409.

  April 17, 2023

   · 

  7 min read
• Genetown

  $134 Million in Financial Backing for Innovative Research and IND Fillings Announced by Ocean Biomedical (NASDAQ: OCEA); Provides Latest Updates on Advancement of Platform, Novel Discoveries in Malaria, Pulmonary Fibrosis and Oncology

  Ocean Biomedical, Inc., a biopharma company working to accelerate the development and commercialization of scientifically compelling assets from research universities and medical centers, shared an update on key company activities.

  April 17, 2023

   · 

  13 min read
• Biotech Bay

  New HeartFlow RoadMap™ Analysis Now Available in U.S. to Assist CT Readers in Identifying Coronary Artery Narrowings

  HeartFlow, Inc. announced the launch of the RoadMap analysis, a new AI-enabled product that assists CT readers to accurately*, efficiently, and consistently identify stenoses in the coronary arteries.

  April 17, 2023

   · 

  3 min read
• BioMidwest

  Launch of chimeric anti-mouse PD1 and PD-L1 recombinant antibodies

  Leinco Technologies (“Leinco”) (St. Louis, MO) today announced the launch of the mAbMods™ chimeric anti-mouse PD1 and PD-L1 recombinant antibodies to target mouse programmed cell death receptor 1 (PD-1) and programmed cell death 1 ligand 1 (PD-L1) in in vivo functional studies.

  April 17, 2023

   · 

  3 min read
• Relief Therapeutics Announces Positive 12-Month Stability Data for Inhaled and Intravenous Preparations of RLF-100

  RELIEF THERAPEUTICS Holding SA announced positive 12-month stability data for the liquid and lyophilized preparations of RLF-100 ®, intended for intravenous and inhaled administration.

  April 17, 2023

   · 

  8 min read